With iOS 18, Apple surprised everyone with a completely new design for its iconic flashlight tool. Now, when you turn on the flashlight on an iPhone, you'll see an elaborate animation showing the ...

The cutting edge system costs just £2 per use THIS is the jawdropping moment Israel’s new Iron Beam interceptor blasts drones out of the sky – as the laser-based system is deployed. Extraordinary ...

Listen to more stories on the Noa app. This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the ...

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial The following represents disclosure information ...

The VP of engineering at a leading technology company stared at the quarterly adoption metrics with growing frustration. Twelve months after rolling out a state-of-the-art AI coding assistant—a tool ...

Dave is a veteran game newswriter and has reported for a variety of outlets for over a decade, writing news, reviews, guides and more for online game sites wherever he can find them. Beam clash ...

Google LLC today unveiled Google Beam, a new artificial intelligence-powered enterprise-focused 3D video communication platform designed to bring remote collaboration closer to in-person interaction.

On the night of May 16, a large beam of light resembling a spotlight was seen shooting into the night sky in the Southwest, but its source remains unknown. A Facebook post sharing the mysterious light ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Alex Bitter Every time Alex publishes a story, you’ll get an alert straight to your inbox!

The CIA claimed to have confirmed the existence of the Ark of the Covenant by way of remote viewing — aka extra sensory perception or ESP — alleging the mysterious and sacred object is guarded by ...

Boston biotech Beam Therapeutics has announced initial data from a phase 1/2 trial of its gene therapy for a genetic lung and liver disease, with no serious adverse events reported among the nine ...